Market snapshot: July 23, 2026, during the U.S. trading session. This is independent research and education, not personal investment advice. Prices move quickly; verify them before trading.
Executive view#
SpaceX is an exceptional operating company. That does not make SPCX automatically attractive at any price. The stock’s first month as a public company has been a collision between a credible long-duration business and an IPO valuation that required nearly flawless execution across launch, Starlink, Starship, and AI-adjacent initiatives.
At roughly $115.86, SPCX is about 23% below its $150 opening trade, 14% below its $135 IPO price, and about 49% below its $225.64 post-IPO high. Yet its market capitalization remains around $1.54 trillion. The decline has reduced enthusiasm; it has not made the shares conventionally inexpensive.
Stance: Wait / accumulate only in cash and in tranches — medium-high confidence. The next meaningful decision point is after the August 4 earnings report and the August 6 lock-up event, not a guess at the intraday bottom.
What happened to the stock?#
The IPO itself priced at $135, opened at $150, traded as high as $176.52 on its first day, and closed that session at $160.95. The initial bid subsequently carried the stock to $225.64. The market was pricing scarcity, retail enthusiasm, index inclusion, and a once-private company with an unusually powerful brand — not just present operating results. IPO pricing and first-day trading
That setup then unwound:
- The end of the IPO underwriter quiet period removed an information vacuum, but also exposed a very wide range of valuation views.
- Nasdaq-100 inclusion created a large, temporary source of passive demand rather than a permanent fundamental catalyst. JPMorgan estimated about $4.3 billion of index-related buying. Contemporaneous market account
- Short interest is unusually intense. Reuters reported that roughly 360 million shares, or 56% of free float, were on loan as of July 22. This can cause sharp rallies as shorts cover, but it is not a substitute for a durable earnings thesis. Reuters
- Most importantly, a new, limited-float IPO is approaching a material increase in tradable supply. That changes the supply-demand balance regardless of the underlying company’s quality.
Fundamentals: a real business, priced for an enormous future#
SpaceX reported $18.67 billion of 2025 revenue and $6.58 billion of adjusted EBITDA. In Q1 2026 it reported $4.7 billion of revenue, $1.1 billion of adjusted EBITDA, and a $1.9 billion operating loss. Its major businesses span launch services, Starlink connectivity, government/defense work, and newer AI-related activities. S-1 figures and business context
Using the approximately $1.54 trillion market capitalization at the July 23 quote, the implied valuation is roughly:
- 82x 2025 revenue
- 234x 2025 adjusted EBITDA
Those are not errors; they are the market’s claim on a future where Starlink’s global network, launch leadership, Starship economics, and adjacent businesses scale dramatically. That upside case is possible. It is also where the risk lives: even excellent growth can produce poor equity returns if the entry valuation already incorporates too much of it.
The company has also issued $25 billion of unsecured senior notes, with coupons ranging from 5.35% to 6.65%, principally to repay bridge financing and for general corporate purposes. The debt is manageable relative to the equity valuation, but it reinforces that execution and future cash generation matter. Company 8-K
Analyst reports: useful inputs, not a consensus reality#
The Street is heavily bullish in rating count but radically split on valuation. That dispersion is the most important takeaway.
- Morningstar: estimated fair value at $63, using probability-weighted scenarios.
- CFRA: Sell, $115 target; cited dependence on unproven Starship commercialization, orbital AI compute, and xAI monetization, plus Starlink capacity, regulatory, and competitive risks. CFRA reasoning and target
- New Street Research: $165 target.
- Oppenheimer: Buy, $190 target.
- Goldman Sachs: Buy, $205 target.
- Citi: $200 target; JPMorgan: $225; Deutsche Bank: $255.
- Morgan Stanley: Overweight, $300 target.
- Raymond James: $800, the extreme bullish outlier.
The high end of the range is built on long-term projections and discount-rate assumptions, not on near-term earnings power. Goldman’s $205 target and Morgan Stanley’s $300 target alone imply roughly a $1 trillion difference in equity value. Both banks were lead IPO underwriters, so their research deserves consideration but also an explicit conflict-of-interest discount. Comparison of the underwriting-bank targets and assumptions
The analyst spread — $63 to $800 — is evidence of extraordinary uncertainty, not evidence that the midpoint is precise.
The next two catalysts matter more than the next headline#
SpaceX is scheduled to report earnings on August 4. A major lock-up expiration follows on August 6, potentially making up to 911.5 million Class A shares eligible for trading; an additional performance-based release may also apply under specified price conditions. Earnings and unlock details
For a long-term investor, that sequence is unusually important. Earnings should clarify Starlink growth, margins, launch economics, capital needs, and management’s outlook. The unlock will test whether new supply is absorbed by genuine demand. Waiting for both is not “missing the dip”; it is avoiding a known source of event risk.
A disciplined long-term buying framework#
No price alone makes a stock safe. The ranges below are a decision framework, not price predictions or instructions.
- Above $115: Wait. The valuation remains extremely demanding and the unlock is still ahead.
- $95–105: Consider a small first cash tranche only if earnings validate Starlink growth and margins, and the post-unlock tape stabilizes.
- $75–90: More compelling risk/reward, though still a valuation that assumes substantial long-term success. Add a second tranche only if the operating thesis remains intact.
- $60–70: This is near the independent $63 fair-value anchor and would offer greater margin of safety. It would also likely mean the market has found new reasons to worry, so verify the facts before buying.
A sensible structure is three or four tranches, separated by company results and major supply events, with a pre-set maximum position size. For a diversified long-term portfolio, this belongs as a small satellite holding, not a core position built on a single narrative.
Margin: the answer is no#
There is no prudent “margin entry price” for SPCX today. Margin converts a temporary drawdown into potential forced selling. This stock has already moved nearly 50% peak-to-trough in a month, has high short interest, and faces an imminent large share unlock. Even a correct long-term thesis can be destroyed by leverage during that path.
If an investor wants exposure, use cash, keep the position modest, and treat the first full public-market earnings cycle as information to earn — not a gamble to finance.
What would change the thesis?#
Reasons to become more constructive: sustained Starlink subscriber and ARPU growth, expanding margins, credible Starship reliability and economics, disciplined capital expenditure, and a clean absorption of unlocked shares.
Reasons to step aside: slowing Starlink economics, material launch/Starship delays, a larger-than-expected cash burn or financing need, weak results hidden behind distant “orbital AI” optionality, or insider supply that overwhelms demand.
The shrewd investor’s edge here is temperament. Separate a brilliant company from a price that already assumes brilliance. Let the first earnings report and the lock-up prove what demand remains when hype, scarcity, and forced index buying are no longer doing the work.